Gene · 140
Papers1,628
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 1,628
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease. | Front Endocrinol (Lausanne) | 2021 | 34938271 | PubTator, text mining | PubMed |
| Gaussian accelerated molecular dynamics (GaMD): principles and applications. | Wiley Interdiscip Rev Comput Mol Sci | 2021 | 34899998 | PubTator, text mining | PubMed |
| An Integrated Analysis Reveals Geniposide Extracted From Gardenia jasminoides J.Ellis Regulates Calcium Signaling Pathway Essential for Influenza A Virus Replication. | Front Pharmacol | 2021 | 34867371 | PubTator, text mining | PubMed |
| Prognostic and immune infiltration signatures of proteasome 26S subunit, non-ATPase (PSMD) family genes in breast cancer patients. | Aging (Albany NY) | 2021 | 34839279 | PubTator, text mining | PubMed |
| Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma. | Nat Commun | 2021 | 34836966 | PubTator, text mining | PubMed |
| Biophysical Stimulation in Athletes' Joint Degeneration: A Narrative Review. | Medicina (Kaunas) | 2021 | 34833424 | PubTator, text mining | PubMed |
| Current Adenosinergic Therapies: What Do Cancer Cells Stand to Gain and Lose? | Int J Mol Sci | 2021 | 34830449 | PubTator, text mining | PubMed |
| BRAF-Inhibitor-Induced Metabolic Alterations in A375 Melanoma Cells. | Metabolites | 2021 | 34822435 | PubTator, text mining | PubMed |
| Purinergic GPCR transmembrane residues involved in ligand recognition and dimerization. | Methods Cell Biol | 2021 | 34752329 | PubTator, text mining | PubMed |
| Caffeine Inhibits Choroidal Neovascularization Through Mitigation of Inflammatory and Angiogenesis Activities. | Front Cell Dev Biol | 2021 | 34722519 | PubTator, text mining | PubMed |
| Pharmacological characterization of DPTN and other selective A3 adenosine receptor antagonists. | Purinergic Signal | 2021 | 34713378 | PubTator, text mining | PubMed |
| Hijacking Sexual Immuno-Privilege in GBM-An Immuno-Evasion Strategy. | Int J Mol Sci | 2021 | 34681642 | PubTator, text mining | PubMed |
| Mechanisms, Pathophysiology and Currently Proposed Treatments of Chronic Obstructive Pulmonary Disease. | Pharmaceuticals (Basel) | 2021 | 34681202 | PubTator, text mining | PubMed |
| Randomised clinical trial: A phase 2 double-blind study of namodenoson in non-alcoholic fatty liver disease and steatohepatitis. | Aliment Pharmacol Ther | 2021 | 34671996 | PubTator, text mining | PubMed |
| Immunosuppressive metabolites in tumoral immune evasion: redundancies, clinical efforts, and pathways forward. | J Immunother Cancer | 2021 | 34667078 | PubTator, text mining | PubMed |
| Profound inhibition of CD73-dependent formation of anti-inflammatory adenosine in B cells of SLE patients. | EBioMedicine | 2021 | 34666225 | PubTator, text mining | PubMed |
| The Effect of Smoking on the Immune Microenvironment and Immunogenicity and Its Relationship With the Prognosis of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer. | Front Cell Dev Biol | 2021 | 34660603 | PubTator, text mining | PubMed |
| A3 Adenosine and P2X7 Purinergic Receptors as New Targets for an Innovative Pharmacological Therapy of Malignant Pleural Mesothelioma. | Front Oncol | 2021 | 34660262 | PubTator, text mining | PubMed |
| Network Pharmacology-Based Study to Uncover Potential Pharmacological Mechanisms of Korean Thistle (Cirsium japonicum var. maackii (Maxim.) Matsum.) Flower against Cancer. | Molecules | 2021 | 34641448 | PubTator, text mining | PubMed |
| Effects of Bacille Calmette Guerin (BCG) vaccination during COVID-19 infection. | Comput Biol Med | 2021 | 34624759 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/140/papers?page=21